125 related articles for article (PubMed ID: 7190203)
1. Steroids with modified ring A or B: screening for potential antiandrogenic and synandrogenic activity.
Stárka L; Hampl R; Bicíková M; Cerný V; Fajkos J; Kasal A; Kocovský P; Kohout L; Velgová H
J Steroid Biochem; 1980 Apr; 13(4):455-60. PubMed ID: 7190203
[No Abstract] [Full Text] [Related]
2. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
Stárka L; Hampl R; Kasal A; Kohout L
J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
[TBL] [Abstract][Full Text] [Related]
3. Androgenic, synandrogenic, and antiandrogenic actions of progestins.
Bullock LP; Bardin CW
Ann N Y Acad Sci; 1977 Mar; 286():321-30. PubMed ID: 281183
[TBL] [Abstract][Full Text] [Related]
4. Assignment of anabolic-androgenic and antiandrogenic properties to some chlorine-substituted steroids on the basis of their binding characteristics to the androgen receptor of the rat seminal vesicle.
Zakár T; Kaufmann G; Tóth M
Exp Clin Endocrinol; 1986 Jul; 87(2):133-41. PubMed ID: 3758193
[TBL] [Abstract][Full Text] [Related]
5. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
7. Evaluation of the use of cyproterone acetate competition to distinguish between high-affinity binding of [3H]-dihydrotestosterone to human prostate cytosol receptors and to sex hormone-binding globulin.
Mobbs BG; Johnson IE; Connolly JG; Clark AF
J Steroid Biochem; 1977 Sep; 8(9):943-9. PubMed ID: 562454
[No Abstract] [Full Text] [Related]
8. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.
Saartok T; Dahlberg E; Gustafsson JA
Endocrinology; 1984 Jun; 114(6):2100-6. PubMed ID: 6539197
[TBL] [Abstract][Full Text] [Related]
9. The baboon prostate as a model for steroid hormone receptors in the human gland.
Karr JP; Kirdani RY; Murphy GP; Sandberg AA
Prog Clin Biol Res; 1979; 33():165-79. PubMed ID: 119228
[No Abstract] [Full Text] [Related]
10. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
[No Abstract] [Full Text] [Related]
11. Androgenic, antiandrogenic, and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors.
Bullock LP; Bardin CW; Sherman MR
Endocrinology; 1978 Nov; 103(5):1768-82. PubMed ID: 748017
[No Abstract] [Full Text] [Related]
12. Partial characterization of [3H]methyltrienolone binding in rat prostate cytosol.
Pousette A; Snochowski M; Bression D; Högberg B; Gustafsson JA
Biochim Biophys Acta; 1979 Jan; 582(2):358-67. PubMed ID: 760830
[TBL] [Abstract][Full Text] [Related]
13. The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.
Sivelle PC; Underwood AH; Jelly JA
Biochem Pharmacol; 1982 Mar; 31(5):677-84. PubMed ID: 6123322
[TBL] [Abstract][Full Text] [Related]
14. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of 4-halo progesterone derivatives as antiandrogen.
Cabeza M; Quiroz A; Bratoeff E; Murillo ME; Ramírez E; Flores G
Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1232-6. PubMed ID: 10517005
[TBL] [Abstract][Full Text] [Related]
16. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
[TBL] [Abstract][Full Text] [Related]
17. Binding of synthetic anabolic steroids to testosterone-estradiol binding globulin and to rat prostate cytosol.
Bicíková M; Hampl R; Stárka L
Endocrinol Exp; 1977; 11(2):85-90. PubMed ID: 301824
[TBL] [Abstract][Full Text] [Related]
18. Relative binding affinities of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5 alpha-reductive steroid metabolism in the dissociation of "myotropic" and "androgenic" activities of 19-nortestosterone.
Tóth M; Zakár T
J Steroid Biochem; 1982 Dec; 17(6):653-60. PubMed ID: 6891012
[TBL] [Abstract][Full Text] [Related]
19. Antiandrogenic activity of a series of des-A-steroid derivatives.
Morales-Alanis H; Brienne MJ; Jacques J; Bouton MM; Nédélec L; Torelli V; Tournemine C
J Med Chem; 1985 Dec; 28(12):1796-803. PubMed ID: 4068004
[TBL] [Abstract][Full Text] [Related]
20. The androgen receptor binding site: a conformational study of steroids in relation with their affinity--I. Interaction with the D-ring.
Schmit JP; Quivy JI; Rousseau GG
J Steroid Biochem; 1980 Dec; 13(12):1387-94. PubMed ID: 7464117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
